Published in Scand J Immunol on May 01, 1994
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect (2001) 1.06
Prenatal PCB exposure and thymus size at birth in neonates in Eastern Slovakia. Environ Health Perspect (2008) 1.02
Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest (1998) 1.01
Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect (1996) 0.96
Developmental Activation of the AHR Increases Effector CD4+ T Cells and Exacerbates Symptoms in Autoimmune Disease-Prone Gnaq+/- Mice. Toxicol Sci (2015) 0.82
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97
A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol (1982) 2.74
Physical exercise and psychological well being: a critical review. Br J Sports Med (1998) 2.25
TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today (1991) 2.06
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med (1983) 1.74
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) (2006) 1.71
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med (1983) 1.66
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis (2006) 1.59
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J Immunol (1983) 1.53
Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry (2001) 1.51
Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev (1976) 1.50
Chronic allogeneic disease. II. Development of lymphomas. J Exp Med (1970) 1.46
Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand (1984) 1.45
The validity of the postcoital test for estimating the probability of conceiving. Am J Obstet Gynecol (1994) 1.40
Nickel allergy versus nickel tolerance: can oral uptake of nickel protect from sensitization? J Environ Monit (2004) 1.39
[The haematogenous reproduction theory of Aristotle]. Ned Tijdschr Geneeskd (2003) 1.39
IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol (1991) 1.37
Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today (1998) 1.30
Metal ion induced autoimmunity. Curr Opin Immunol (1995) 1.26
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Ann Rheum Dis (2005) 1.26
The murine IgG1/IgE class switch program. Eur J Immunol (1992) 1.25
Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci U S A (1989) 1.22
The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. Br J Clin Pharmacol (1998) 1.22
A simple sperm penetration test. Int J Fertil (1966) 1.16
Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol (1990) 1.16
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. V. High titers of IgG autoantibodies to double-stranded DNA. J Immunol (1981) 1.16
Neutrophils and drug metabolism. Science (1995) 1.15
Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol (1983) 1.14
Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. J Natl Cancer Inst (1972) 1.14
The sperm-cervical mucus contact test: a preliminary report. Fertil Steril (1976) 1.11
Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways. Am J Clin Pathol (1979) 1.10
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD. J Immunol (1984) 1.09
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum (2008) 1.08
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr (2010) 1.08
Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med (1972) 1.08
Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. J Immunol (1984) 1.05
Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol (1997) 1.00
Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune "suppression" locus for HgCl2-induced antinucleolar autoantibodies. Eur J Immunol (1989) 0.99
Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J Immunol (1985) 0.98
Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease. Clin Exp Immunol (1990) 0.97
Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect (1996) 0.96
The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol (2000) 0.96
Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol (1985) 0.96
Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer. J Immunol (1986) 0.95
Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy Appl Immunol (1989) 0.95
High voltage cryomicroscopy of human blood platelets. J Struct Biol (1993) 0.93
The significance of the Fc part of antispermatozoal antibodies for the shaking phenomenon in the sperm-cervical mucus contact test. Fertil Steril (1981) 0.92
Xylem water content and wood density in spruce and oak trees detected by high-resolution computed tomography. Plant Physiol (2001) 0.92
Identification of dioxin-responsive elements (DREs) in the 5' regions of putative dioxin-inducible genes. Chem Biol Interact (1996) 0.92
The classification of antiseptic products to be administered to wounds--another borderline case between medicinal products and medical devices? Int J Clin Pharmacol Ther (2006) 0.92
The specificity of depressive symptoms in patients with Alzheimer's disease. Am J Psychiatry (2001) 0.91
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes. J Immunol (1981) 0.91
Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities. Arch Toxicol (1997) 0.90
Mercuric-chloride-induced autoimmunity in mice involves up-regulated presentation by spleen cells of altered and unaltered nucleolar self antigen. Int Arch Allergy Immunol (1995) 0.90
Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1. Cell Death Differ (2013) 0.90
Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol (1996) 0.90
Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol (1996) 0.90
Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J Immunol (1994) 0.90
Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E). Clin Exp Immunol (1986) 0.89
MHC control of IL-4-dependent enhancement of B cell Ia expression and Ig class switching in mice treated with mercuric chloride. Int Arch Allergy Immunol (1993) 0.89
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. IV. Autoantibodies to nuclear antigens. Clin Exp Immunol (1981) 0.89
Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol (1999) 0.89
A simple method of screening for antisperm antibodies in the human male. Detection of spermatozoal surface IgG with the direct mixed antiglobulin reaction carried out on untreated fresh human semen. Int J Fertil (1978) 0.88
The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clin Exp Rheumatol (2009) 0.88
Immunopathological signs in mice treated with mercury compounds--I. Identification by the popliteal lymph node assay of responder and nonresponder strains. Int J Immunopharmacol (1988) 0.88
Isolation of full-size mRNA from ethanol-fixed cells after cellular immunofluorescence staining and fluorescence-activated cell sorting (FACS). Cytometry (1995) 0.88
Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro. Acta Derm Venereol (1997) 0.87
Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Eur J Immunol (1989) 0.86
The induction of organ-specific antibodies during the graft-vs.-host reaction. Eur J Immunol (1988) 0.86
Hypo-osmotic sperm swelling test does not assess fertilizing capacity of human spermatozoa. Arch Androl (1991) 0.85
Psychosocial aspects of parenthood by artificial insemination donor. Lancet (1984) 0.85
Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J Immunol (1999) 0.85
Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells. J Exp Med (1984) 0.85
Intra-H-2 and T cell requirements for the induction of maximal positive and negative allogeneic effects in vitro. Eur J Immunol (1983) 0.85
Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats. Crit Rev Toxicol (1995) 0.84
Strong associations of psoriasis with antigen processing LMP and transport genes TAP differ by gender and phenotype. Genes Immun (2007) 0.84
Genetic differences in immune reactivity to mercuric chloride (HgCl2): immunosuppression of H-2d mice is mediated by interferon-gamma (IFN-gamma). Clin Exp Immunol (1997) 0.84
Comparative studies on the toxicity of mercury, cadmium, and copper toward the isolated perfused rat liver. J Toxicol Environ Health (1996) 0.84
Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol (1987) 0.84
Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Arch Androl (1985) 0.84
Treatment of infertility caused by antisperm antibodies. Int J Fertil (1978) 0.83
Hemodynamics of the varicocele. Part II. Correlation among the results of renocaval pressure measurements, varicocele scintigraphy and phlebography. J Urol (1986) 0.83
Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment. J Rheumatol (2001) 0.83
Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer. J Surg Oncol (1988) 0.82
Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model. J Natl Cancer Inst (1975) 0.82
Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes. Int J Immunopharmacol (1999) 0.82
Depressed antibody responses to exogenous antigens in mice with lupus-like graft-versus-host disease. Clin Immunol Immunopathol (1987) 0.82
Increased frequencies of cytochrome P4501A1 polymorphisms in infertile men. Andrologia (1998) 0.82